联合王国卫生官员对使用GLP-1药物的病人与胰腺炎的遗传联系进行调查。 UK health officials investigate genetic links to pancreatitis in patients using GLP-1 drugs.

联合王国卫生官员正在研究遗传因素是否会影响与用于减肥和糖尿病的GLP-1型药物有关的胰腺炎病例。 Health officials in the UK are studying if genetic factors could influence cases of pancreatitis linked to GLP-1 drugs, used for weight loss and diabetes. 自这些药物获得批准以来,已报告数百例胰腺炎病例,其中一些是致命的。 Since these drugs were approved, hundreds of pancreatitis cases have been reported, some fatal. 药品和保健产品管理局正在收集因胰腺炎住院的病人的数据,同时利用GLP-1药物更好地预测高危人群,并根据遗传学使药物更安全。 The Medicines and Healthcare products Regulatory Agency is collecting data from patients who were hospitalized for pancreatitis while using GLP-1 medicines to better predict those at risk and make medication safer based on genetics.